Introduction {#Sec1}
============

Chronic pain represents an urgent global health problem \[[@CR1]\] that incurs massive social and economic costs \[[@CR2], [@CR3]\]. Highly prevalent, chronic pain affects between 19 and 43% of the US population \[[@CR4]--[@CR8]\]. A substantial portion of the chronic pain population is comprised of those with bone/joint pain \[[@CR7]\], where osteoarthritis (OA) and rheumatoid arthritis (RA) are considered to be among the most disabling of the chronic bone/joint diseases \[[@CR9]--[@CR11]\]. At the population level, over 20% of adults under 65 years old, and almost 50% of adults over 65, have some form of arthritis \[[@CR12]\]. A substantial proportion of this population have restricted joint motion, muscle weakness, substantial activity limitations, and are physically inactive \[[@CR12]--[@CR19]\]. As such, arthritis is thought to be the main cause of disability in the USA, with a socio-economic impact approaching \$200 billion annually as of 2007 \[[@CR20]\].

Three main treatment modalities are available for bone/joint diseases such as OA and RA: surgical, pharmacological, and non-pharmacological \[[@CR21], [@CR22]\]. While surgical and pharmacological treatments can certainly be beneficial \[[@CR23], [@CR24]\], these approaches are not without risk and/or unpleasant secondary effects \[[@CR22], [@CR25], [@CR26]\]. Indeed, referrals for orthopedic surgical interventions are often indicated only after less invasive treatment options have been exhausted \[[@CR27]\]. As such, non-pharmacological approaches are increasingly recommended as first-line treatments for certain types of chronic pain, even prior to pharmacological interventions \[[@CR28]\]. An increasingly popular non-pharmacological approach is exercise, which has been defined as "planned, structured, and repetitive bodily movements that are performed to improve or maintain one or more components of physical fitness" \[[@CR29]\]. The beneficial effects of exercise are undeniable, both for maintaining health and for reducing the negative impacts of many chronic illnesses including cancer, type 2 diabetes, obesity, and depression \[[@CR30]--[@CR33]\]. In this brief review, our goal is to survey the current state of knowledge on the effects of exercise on chronic pain outcomes both in humans and in rodent models of chronic pain. Considering the number of high-quality reviews and meta-analyses that have critically appraised the literature on the effects of aerobic exercise in chronic bone/joint pain in humans, we will only outline their main conclusions. We will, however, discuss the limited rodent literature in more detail. Finally, we will discuss these rodent findings in light of the human studies.

Is Exercise Beneficial for Chronic Pain in Humans? {#Sec2}
==================================================

Habitual physical inactivity is one of the leading risk factors driving non-communicable diseases and death worldwide \[[@CR34]--[@CR37]\]. Sedentary lifestyles are associated with poorer health as well as reduced day-to-day functioning and quality-of-life \[[@CR13], [@CR38]--[@CR40]\], where even intermittent bouts of vigorous activity appear to be unable to counteract the impacts of habitual physical inactivity \[[@CR13], [@CR39], [@CR40]\]. Regular physical activity, however, can be effective in both prevention and treatment of many chronic diseases \[[@CR30]--[@CR32]\]. In healthy individuals, there is a long history of support for analgesic effects of regular physical activity, particularly highly aerobic exercises such as endurance running/cycling \[[@CR41]--[@CR43]\]. Additional benefits include the reduction of depression, anxiety, and stress \[[@CR44]--[@CR48]\]. Increasingly, guidelines state that exercise should be part of the core treatment for chronic pain \[[@CR28], [@CR49]--[@CR52]\], generally advising low-to-moderate levels of physical activity that are increased incrementally (i.e. "*Start low, go slow*") and monitored by a qualified health care professional. The effects of regular exercise for chronic pain and its comorbidities has been the subject of many primary research reports, reviews, and meta-analyses over the last 30 years. Rather than attempt to re-evaluate the surfeit of primary literature, we will instead briefly report the main conclusions from a few recent Cochrane reviews that have carefully collated this massive and diverse literature into a more digestible format.

Among the most up-to-date and comprehensive reviews is a Cochrane review from Geneen et al. \[[@CR53]••\]. Geneen et al. assessed 21 previous Cochrane reviews, incorporating 264 primary reports and 19,642 participants, to determine the effectiveness of different physical exercise interventions in reducing pain stemming from various chronic pain syndromes. Overall, while exercise resulted in reduced pain severity and improved physical function in various forms of chronic pain, effects were small-to-moderate at best and were quite inconsistent across reviews. Exercise-induced effects on psychological function and quality of life were equally variable. Nonetheless, exercise was associated with few adverse events as well as improved pain severity, physical function, and quality of life. Similarly, in a 2014 Cochrane review assessing therapeutic exercise for hip OA in 9 trials (549 participants), Fransen et al. \[[@CR54]\] reported high-quality evidence in support of exercise-induced improvements in pain and physical function in individuals with hip OA. In another Cochrane review from the same group based on 44 trials (3537 participants), Fransen et al. \[[@CR55]\] reported that therapeutic exercise produced short-term improvements in pain and physical function in individuals with knee OA. However, the lack of blinding in most trials (i.e., participants being aware of their treatment group) may have contributed to the improvement.

In terms of the relative effects of different types or intensities of exercise, O'Connor et al. \[[@CR56]\] assessed 17 studies on walking exercise in individuals with chronic low back pain, OA, or fibromyalgia. Overall, walking produced a small-to-medium improvement in pain and physical function in the short term, whereas longer-term effectiveness was uncertain. Regneaux et al. \[[@CR57]\] included 6 reports comparing the effects of high- or low-intensity exercise in 656 participants experiencing hip or knee OA. Overall, high-intensity exercise did not seem to provide any clinical benefit over low-intensity exercise in terms of pain and physical function. Regneaux et al. \[[@CR57]\] indicated that the paucity of studies comparing high- and low-intensity exercise programs in OA points to the need for research focusing on the minimal exercise intensity required for clinical effect as well as the highest intensity considered both safe and tolerable. In the same vein, Golightly et al. \[[@CR58]••\] reviewed 39 studies focusing on the effects of aerobic and strength training exercise on OA-related pain and physical function. They showed that while both forms of exercise improved pain and function, there was no difference in effectiveness between the types of exercise programs studied (i.e., aerobic vs. strengthening regimens). Similarly, a recent meta-analysis of 48 randomized controlled trials on the effects of exercise on OA pain also showed an overall moderate benefit of exercise on pain, regardless of exercise type \[[@CR59]•\]. However, Juhl et al. reported (i) that regular aerobic exercise (i.e., at least three times per week for 12 weeks) was more impactful than the intensity of aerobic exercise; (ii) that exercise programs using a single type of exercise (i.e., aerobic exercise, strength training) were more effective than programs mixing multiple types into the same exercise session \[[@CR59]•\], but see \[[@CR60]\]; and (iii) there was no evidence to support individualized exercise programs based on patient characteristics including radiographic severity of OA. In addition to these points, another important consideration is the duration of exercise-induced effects. A number of groups have indicated that exercise-induced OA benefits appear to fade once the exercise program is discontinued \[[@CR56], [@CR61], [@CR62]\], underlining the importance of continued engagement in exercise programs in order to maintain beneficial effects. Indeed, improved adherence to exercise programs seems to be a stronger predictor of improvement in pain and physical function associated with knee OA than exercise frequency or intensity \[[@CR63]--[@CR65]\]. Taken together, while exercise appears to be beneficial for many types of chronic pain, a number of qualifications are in order: Firstly, no intensity or approach appears to be superior to another. Secondly, the available evidence does not appear to support individualized exercise programs. Thirdly, greater adherence to exercise programs yields better outcomes. Finally, benefits do not seem to last much longer than the duration of exercise program.

Is Exercise Beneficial for Mental Health Impacts of Chronic Pain? {#Sec3}
-----------------------------------------------------------------

Aerobic exercise can improve depression to a level similar in scope to either psychological or pharmacological therapies \[[@CR33]\]. Considering that depression affects between 20 and 35% of the chronic pain population \[[@CR7], [@CR66], [@CR67]\] and can be considered a consequence of chronic pain \[[@CR68], [@CR69]\], establishing the effectiveness of exercise against comorbid depression has clear clinical relevance. While some studies indicate that aerobic exercise improved depression comorbid with fibromyalgia \[[@CR70], [@CR71]\], only 5 of the 21 Cochrane reviews assessed in Geneen et al. \[[@CR53]\] reported mental health/depression outcomes, with positive yet somewhat variable results. While the existing literature indicates that exercise for depression comorbid with chronic pain is at least moderately effective, more randomized controlled trials of high methodological quality are needed.

Mechanisms of Exercise-Induced Benefits in Chronic Pain {#Sec4}
-------------------------------------------------------

Activation of the endogenous opioid system has long been proposed to be the main biochemical mechanism underlying exercise-induced analgesia reviewed in \[[@CR41], [@CR65], [@CR72], [@CR73]\], as well as the euphoric state commonly referred to as 'runners high' \[[@CR74]\]. However, these effects seem to occur acutely post-exercise and are largely dependent on exercise intensity, where a dose-response relationship exists between exercise intensity and reward/affective response \[[@CR75]\] and perhaps also with anti-nociception \[[@CR76]\]. Indeed, vigorous exercise (i.e., greater than 70% of the maximum aerobic capacity \[VO~2~^max^\], or the range required to improve cardiovascular fitness in healthy individuals) seems to be required to produce endogenous opioid release \[[@CR77], [@CR78]\], reviewed in \[[@CR79]\] \[[@CR80]\]. As such, benefits associated with lower intensity exercise (i.e., walking at an intensity substantially below 70% of VO~2~^max^) may involve longer-term engagement of the endogenous opioid system along with other endogenous systems. Another avenue by which exercise can reduce pain involves factors such as weight loss and other musculoskeletal benefits. Considering that excess weight plays an important structural role in OA pain \[[@CR16], [@CR81], [@CR82]\], it is clear that weight loss can be beneficial \[[@CR83], [@CR84]\]. However, in terms of other musculoskeletal outcomes such as muscle function, the amount of benefit in pain does not necessarily correlate with the amount of benefit in these outcomes, suggesting that factors other than improved musculoskeletal function may be mediating pain relief \[[@CR85]\]. Taken together, mechanisms of exercise-induced attenuation of persistent pain, especially pain relief associated with low-intensity exercise, remain unclear.

Is Exercise Beneficial in Rodent Models of Chronic Pain? {#Sec5}
========================================================

Given the variability and other challenges inherent in human clinical trials, the apparent difficulty in isolating factors underlying exercise-induced analgesia is perhaps not surprising. Rodent studies, however, allow precise control of biological and environmental factors, as well as experimental interventions. As such, they should be well placed to probe these questions. A careful search of the biomedical research repository Pubmed (<https://www.ncbi.nlm.nih.gov/pubmed>) was performed using the search terms "exercise" and "chronic pain" or "pain" in non-human animal research. Only studies incorporating land-based physical exercise (i.e., voluntary wheel running or treadmill running; Fig. [1](#Fig1){ref-type="fig"}) as a primary intervention were included. Studies in which access to exercise was not ensured for each animal (i.e., environmental enrichment paradigms with a single voluntary exercise wheel for numerous cage mates) were not included in this review. Review articles, studies not focused on rodent models of persistent pain, and studies lacking pain/hypersensitivity outcomes were also excluded from this assessment. This search strategy revealed no less than 43 studies focused on the effects of exercise in rodent models of persistent pain (Tables [1](#Tab1){ref-type="table"} and [2](#Tab2){ref-type="table"}). In the context of these studies, we discuss the impact of a number of factors including the type of chronic pain model (neuropathic, osteoarthritis, etc), species (rat, mouse), gender (male, female), exercise modality (forced treadmill running, voluntary wheel running), and exercise intensity characteristics (i.e., duration, frequency and velocity). While most studies used exercise as a therapeutic intervention (i.e., main exercise paradigm initiated post-injury), a number used exercise preventatively (i.e., exercise initiated pre-injury) or integrated both pre- and post-injury exercise into a single paradigm. Given that preventative paradigms may influence not only the maintenance of persistent pain states, but also the development of pain, we considered preventative exercise paradigms (Table [1](#Tab1){ref-type="table"}) separately from therapeutic exercise paradigms (Table [2](#Tab2){ref-type="table"}).Fig. 1Rodent exercise paradigms. **a**. Forced treadmill running involves placing the rodent in an inescapable enclosure, either with or without an electrical shock grid to reinforce running behavior. Speed and incline of the treadmill can be adjusted. **b**. Voluntary wheel running paradigms yield either restricted or unrestricted access to the running wheel. During access, the rodent is free to run as much or as little as desiredTable 1Preventative exercise in rodent models of chronic painReferencePain modelSex and SpeciesExercise modality ± reinforcementPre-trainingExercise intensityMaximal running velocityTime delay between exercise and testingEffective for mechanical hypersensitivity?Effective for thermal hypersensitivity?Other outcomesCobianchi et al. 2010CCI (NP)Male miceTreadmill + shockNo60 min/day, 5 days/week, 2 weeks30 m/min3 daysNon/an/aStagg et al. 2011SNL (NP)Male ratsTreadmill + shock\
(some excluded for stress/not running)No10 min/day, 2 days/week, 2 weeks18 m/min\~ 7 daysNoNon/aSluka et al. 2013MuscleMale miceVoluntaryNo24 h/day, 7 days/week, 5 days or 8 weeksn/a6 daysYes: 8 weeks, effect lost by 1 week\
No: 5 daysn/aReduced phosphorylation of NMDA-NR1 in RVMGong et al. 2016IncisionFemale rats (neonatal)Treadmill + shock (excluded poor runners)No30 min/day, 6 days/week, 3 weeks15 m/min4 daysNoNon/aGrace et al. 2016CCI (NP)Male ratsVoluntaryNo24 h/day\
7 days/week, 6 weeksn/a1 dayYes: effect lasted for 13 weeks post-exercisen/aNormalized IL-1b, GLT-1, P2X4R-BDNF. Reduced macrophage activity and CCL2 chemokine. Increased IL-10.Kami et al. 2016APSNL (NP)Male miceTreadmill + proddingNo10--60 min/day, 5 d/week, 2 weeks7 m/min2 daysNoNon/aKami et al. 2016BPSNL (NP)Male miceTreadmill + shock + proddingNo10--60 min/day, 5 day/week, 2 weeks7 m/min2 dysNoNon/aLeung et al. 2016MuscleMale and female miceVoluntaryNo24 h/day\
7 days/week, 8 weeksn/a6 daysYes: Only tested 1 day post-injury. No gender differences.n/aMuscle macrophage and increasing IL-10Sabharwal et al. 2016MuscleMale and female miceVoluntaryNo24 h/day\
7 days/week, 5 days or 8 weeksn/a6 daysYes: 5 days = 8weeks.\
Only tested 1 day post-injury. No gender differences.n/aPrevented development of autonomic dysfunction (i.e., reduced HRV)Wakaizumi et al. 2016PSNL (NP)Male miceTreadmillNo60 min/day,\
5 days/week, 2 weeks6--12 m/min5 daysNon/an/aSafakhah et al. 2017CCI (NP)Male ratsTreadmill5 days, 10 min/day, 10 m/min30 min/day,\
5 days/week, 3 weeks16 m/min27 daysNoNon/a*CCI* chronic constriction injury, *PSNL* partial sciatic nerve ligation, *SNL* spinal nerve ligation, *Muscle* muscle pain, *Incision* incision, *NP* neuropathic pain model, *n/a* not applicable, *PID* post-injury day, *m/min* meters per minuteTable 2Therapeutic exercise in rodent models of chronic painReferencePain modelSex and speciesExercise modality ±  reinforcementPre-trainingExercise initiatedExercise intensityMaximal running velocityEffective for mechanical hypersensitivity?Effective for thermal hypersensitivity?Other outcomesHutchison et al. 2004SCI (NP)Female ratsTreadmill + positive reinforcement1 week, 12 m/minPID 425 min/day,\
5 days/week, 7 weeks12 m/minYesn/aRestored BDNF signalingBement et al. 2005MuscleMale ratsTreadmill (some excluded)3 days, 5 min/day, 3 m/minPID 130 min/day, 5 days6 m/minYesn/aOpioid-dependent effect of exerciseCobianchi et al. 2010CCI (NP)Male miceTreadmill + shock (some excluded)2 weeks, 60 min/day, 5 days/week, 30 m/minPID 360 min/day, 5 days, or 8 weeks30 m/minYes 5 days\
No \> 5 daysn/aShorter duration reduced microglia/astrocyte expression, better nerve regenerationKorb et al. 2010SNSR (NP)Male ratsTreadmill4 days, 10 min/day, 5 m/min, then max testPID 760 min/day,\
5 days/week, 4 weeks9 m/minYesn/aSerotonin activity in the spinal cordSharma et al. 2010MuscleFemale miceTreadmill + prodding3 days, 13 m/minPID 545 min/day,\
5 days/week, 3 weeks16 m/minYesn/aNT-3 expression increasedStagg et al. 2011SNL (NP)Male ratsTreadmill + shock\
(some excluded for stress/not running)2 weeks, 2 day/week, 10 min/day, 18 m/min, 8% gradePID 7 or 2830 min/day,\
3 days/week or 5 days/week, 5 weeks10--16 m/minYes: 3 days/week = 5 days/week\
Yes: 7 days delay = 8 days delay.\
Yes: 16 m/min.\
No: 10 m/min\
In all cases, exercise effects lost \~ 5 days.YesOpioid-mediated effects in the RVM and the PAGShankarappa et al. 2011Diab (NP)Male ratsTreadmill + shock5 days, 60 min/day, 18 m/minn/a60 min/day,\
5 days/week, 10 weeks18 m/minYesNo change in diabetic ratsOpioid-mediated. Ca2+-mediated changes in DRG neuronsChen et al. 2012CCI (NP)Male ratsTreadmill (no shock)3 days, 15 min/day, 20 m/minPID 260 min/day, 5 days/week, 6 weeks30 m/minYesYesIncreased Hsp-72 and decreased IL-1b, TNF⍺Chen et al. 2013ADiab (NP)Male ratsTreadmill (some excluded)n/aNot indicated60 min/days, 7 days/week, 8 weeks20 m/minYesYesReduced blood glucose levels and increased Hsp-72 but no effect on IL-6, TNF⍺Chen et al. 2013BIncisionMale ratsTreadmill3 days 15 minPID 855 min/day, 5 days/week, 4 weeks18 m/minYes, partial reversaln/aLower NMDA-NR1, TNF⍺, and IL-6 in the spinal cordCobianchi et al. 2013SNSR (NP)Female ratsTreadmill + shockn/aPID 360 min/day, 5 days19 m/minYes, partial reversalNoImproved axonal regeneration, reduced BDNF, NGF, and GDNF in DRGGroover et al. 2013Diab (NP)Male miceVoluntaryn/aPID 124 h/day\
7 days/week, 12 weeksn/aYes: 6wks to take effect.No change in diabetic ratsReduced metabolic abnormalities. Improved innervation and neurotrophin levels (TrkA, NGF, BDNF)Morimoto et al. 2013CastMale ratsTreadmill3 daysPID 330 min/day,\
3 days/week, 2 weeks12 m/minYesn/aRange of motion and calf muscle atrophy improvedChen et al. 2014IncisionMale ratsTreadmill + shockn/aPID 660 min/day, 5 days/week, 4 weeks18 m/minYes, partial reversaln/aReduced substance P, IL-1b, IL-6, in DRGDetloff et al. 2014SCI (NP)Female ratsAutomated running wheels (forced)n/aPID 520 min/day,\
5 days/week, 5 weeks14 m/minYes: Immediately effective.NoGDNF, artemin maintained at normal levelsBobinski et al. 2015SNC (NP)Male miceTreadmill1 week, 10 min/day, 10 m/minPID 330 min/day,\
5 days/week, 2 weeks10 m/minYesn/aBrainstem serotonin increased, while TNF⍺ and IL-1b were reducedChen et al. 2015Diab (NP)Male ratsTreadmill + prodding3 days, 15 min/day, 10 m/minPID 360 min/day, 7 days/week, 4 weeks25 m/minYesYesIncreased IL-10 and decreased IL-6, TNF⍺, MDAChuganji et al. 2015CastMale ratsTreadmilln/aPID 030 min/day,\
5 days/week, 8 weeks15 m/minYesn/aβ-endorphin increased in PAG and hypothalamusLopez-Alvarez et al. 2015SNSR (NP)Female ratsTreadmill1 h, 19 m/minPID 360 min/day, 5 days or 10 days19 m/minYesYesPrevented changes in peripheral innervation and disruption of Cl co-trans. Reduced NGF, BDNFKim et al. 2015CCI (NP)Male ratsTreadmilln/aNot indicated30 min/day,\
5 days/week, 4 weeks22 m/minYesYes, partial reversalReduced Mu opioid receptor expression in RVM and spinal cordLuan et al. 2015DiscMale ratsTreadmilln/aPID 1440 min/day,\
7 day/week, 1--8 weeks13 m/minYesn/aImproved degenerated discs and neurogenesis in and around discSheahan et al. 2015SNI (NP)Male miceVoluntaryn/aPID 8--102--12 h/day,\
5--6 d/week, 1 or 4 weeksn/aNoNoIneffective in reversing muscle wasting or denervation.Yoon et al. 2015Diab (NP)Male ratsTreadmill2 days, 20 min/day, 5 m/minPID 760 min/day,\
5 days/week, 6 weeks10 m/minYesYesIncreased enkephalin, HSP70; decreased TNF⍺, IL-1b, TRPV1, TRPM8, pp38 in the DRGDetloff et al. 2016SCI (NP)Female ratsAutomated running wheels (forced)n/aPID 14 or 2820 min/day,\
5 days/week, 5 weeks14 m/minNon/aGong et al. 2016IncisionFemale rats (neonatal)Treadmill + shock\
(excluded poor runners)n/aPID 2230 min/day, 6 days/week, 2 weeks15 m/minNoNoReduced high P38 MAPK, 1L-1b, TNF⍺ (but not IL-6).Grace et al. 2016CCI (NP)Male ratsVoluntaryn/aPID 0 or 1424 h/d\
7 days/week, 2 weeks or 11 weeksn/aYes: 2wks = 11wksn/aNormalized IL-1b, GLT-1, P2X4R-BDNF. Reduced macrophage activity and CCL2 chemokine. Increased IL-10.Kami et al. 2016APSNL (NP)Male miceTreadmill + prodding10--60 min/day, 7 m/min, 2 weeksPID 260 min/day,\
5 day/week, 5 days7 m/minYesYesBlocked decrease in GABA/GAD65/67 reductions in dorsal hornKami et al. 2016BPSNL (NP)Male miceTreadmill + prodding10--60 min/day, 7 m/min, 2 weeksPID 260 min/day, 5 day/week, 5 day7 m/minYesYesReduced histone deacetylase1+/CD11b+ microglia in spinal cordWakaizumi et al. 2016PSNL (NP)Male MiceTreadmill3 options:\
- None\
- 2 weeks, 1 h/day,\
5 days/week, 6 m/min\
-  2 weeks, 1 h/day,\
5 days/week, 12 m/minn/a60 min/day,\
5 days/week, 1 week (fast) or 2 weeks (slow)6 m/min or 12 m/minYes: 2wks pre + 2wks post, slow.\
Yes: 2wks post, slow.\
Yes: 2wks pre + 1wk post, fast.\
No: 1wk post, fast.Yes: 2wks, slowMesolimbic dopamine activityAllen et al. 2017MIA (OA)Male RatsTreadmill + shockn/aPID 1030 min/day,\
4 days/week, 4 weeks16 m/minYesn/aOpioid-mediated effects. Exercise improved trabecular bone microarchitecture.Arbat-Plana et al. 2017SNSR (NP)Female RatsTreadmill + shockn/aPID 360 min/day, 5 days/week, 2 weeks18 m/minYesn/aBDNF/TrkB signaling maintaining functional spinal neuro-circuitry.Bobinski et al. 2017SNC (NP)Male MiceTreadmilln/aPID 330 min/day,\
5 days/week, 2 weeks10 m/minYesn/aIncreased IL-4Cormier et al. 2017MIA (OA)Male RatsVoluntary1 or 3 weeksPID 024 h/day\
7 days/week, 3 weeksn/aYes: 3wks pre + 3wks post.\
No: 1wk pre + 3wks post.n/aImproved trabecular bone microarchitecture.Huang et al. 2017CCI (NP)Male ratsTreadmill + proddingn/aPID 830 min/day,\
7 days/week, 3 weeks16 m/min (8% grade)YesYesReduced IL-6 and TNF⍺ and increased IL-10Lopez-Alvarez et al. 2017SNSR (NP)Female ratsTreadmill60 min, 19 m/minPID 360 min/day, 12 day19 m/minYesYesMonoaminergic (5HT) descending pathways, and BDNF and microglia in locus coeruleusPitcher et al. 2017CFA (OA)Male ratsVoluntaryn/aPID 32 h/day,\
4 d/week, 3 weeksn/aYesYesDecreased stress, increased HRV, no change in swelling. No association between running and benefitSafakhah et al. 2017CCI (NP)Male ratsTreadmill (some excluded)5 days, 10 min/day, 10 m/minPID 530 min/day,\
5 days/week, 3 weeks16 m/minYesYesDecreased TNF⍺ and increased FRAPTsai et al. 2017CCI (NP)Male ratsTreadmill + proddingn/aPID 630 min/day,\
7 days/week, 3 weeks14--16 m/min (8% grade)Yes: 8% incline better than 0%.Yes: 8% incline better than 0%.Decreased TNF⍺ and IL-6 and prevented downreg of IL-10Whitehead et al. 2017CCI (NP)Male ratsVoluntary1wk, 60 min/dPID 2--360 min/day,\
7 days, 18 daysn/aNon/aYamaoka et al. 2017SNL (NP)Female ratsTreadmilln/aPID 120 min/day,\
5 days/week, 6 weeks20 m/min (10° incline)YesYes, partial reversal*CCI* chronic constriction injury, *PSNL* partial sciatic nerve ligation, *SNL* spinal nerve ligation, *SNI* spared nerve injury, *SNSR* sciatic nerve section and repair, *SCI* spinal cord contusion injury, *SNC* sciatic nerve crush, *Diab* diabetic neuropathy, *MIA* Mono-iodoacetate, *CFA* complete Freund's adjuvant, *Muscle* muscle pain, *Incision* incision, *Cast* cast immobilization, *Disc* disc degeneration, *OA* osteoarthritis model, *NP* neuropathic pain model, *n/a* not applicable, *PID* post-injury day, *m/min* meters per minute

Preventative Exercise {#Sec6}
---------------------

A number of studies incorporated experiments that were designed specifically to assess the effectiveness of preventative exercise on the development of persistent pain in rodents (Table [1](#Tab1){ref-type="table"}). Of the 11 studies employing preventative exercise paradigms, 7 used neuropathic pain models (64%), 3 used a model of chronic muscle pain (27%), and 1 study used a model of incisional pain (9%). A total of eight studies used male rodents (73%), whereas two studies used both males and females (18%) and one used only females (9%). Seven studies used mice (64%), while the remaining four used rats (36%). Seven studies used a forced treadmill running paradigm (64%), while the remaining four employed voluntary wheel running (36%). In terms of exercise characteristics, all of the studies employing voluntary running allowed rodents unrestricted access to running wheels for a duration between 5 days and 8 weeks. While the duration of forced treadmill running studies was fairly uniform (i.e., 2--3 weeks), their frequency ranged from 10 min per day twice a week to 1 h per day for 5 days a week. Maximal running velocity in studies using voluntary running wheels was not reported. However, the maximal running velocity used in forced treadmill studies ranged between 6 and 30 m/min.

A total of four studies reported that preventative exercise paradigms reduced mechanical hypersensitivity \[[@CR86]--[@CR88], [@CR89]••\]. These studies all used voluntary exercise, where rodents had unrestricted access to running wheels. Moreover, three of the four voluntary exercise studies employed a muscle pain model \[[@CR86], [@CR88], [@CR89]••\], whereas the fourth used a neuropathic pain model \[[@CR87]\]. Exercise of longer duration, beginning 6--8 weeks prior to pain induction, appeared to be most effective \[[@CR86]--[@CR88]\] but see \[[@CR89]••\]. In terms of the duration of exercise-induced benefits, while Grace et al. reported long-lasting effects of preventative exercise for neuropathic pain \[[@CR87]\], the beneficial effects of exercise on chronic muscle pain lasted no longer than 3 days post-induction \[[@CR86], [@CR88], [@CR89]••\]. In the two studies using both male and female rodents, no sex differences in the effects of exercise were observed \[[@CR88], [@CR89]••\]. Of the five studies assessing thermal hypersensitivity, all employed forced treadmill running paradigms. However, none found preventative exercise to be effective at reducing thermal hypersensitivity (Table [1](#Tab1){ref-type="table"}). Overall, among the studies where preventative exercise was not effective at reducing hypersensitivity, all used forced treadmill running in models of neuropathic pain \[[@CR90], [@CR91]•, [@CR92]--[@CR96]\]. As such, it appears that the exercise paradigm (i.e., voluntary exercise), the amount of running (i.e., unrestricted wheel access), and possibly the model of chronic pain, may all contribute to the effectiveness of preventative exercise paradigms in rodent models of chronic pain.

Therapeutic Exercise {#Sec7}
--------------------

A total of 40 studies initiated the main exercise program therapeutically, after the onset of experimental models of chronic pain in rodents (Table [2](#Tab2){ref-type="table"}). Over half of these studies used therapeutic exercise that was preceded by some level of pre-training prior to injury (21/40, or 52.5%). None of these studies reported an analgesic effect of pre-training on early post-injury hypersensitivity. As such, these studies are considered in the context of therapeutic exercise.

Of the 40 studies employing therapeutic exercise paradigms, 29 used neuropathic pain models (72.5%), 3 used models of osteoarthritis (7.5%), 3 used incision models (7.5%), and 5 used other models (12.5%). A total of 30 studies used male rodents (75%), whereas 10 studies used females (25%). The majority of studies used rats (31 or 77.5%), while the remaining nine studies used mice (22.5%). In most cases, a forced running paradigm was used (34 studies, or 85%). In these studies, exercise was performed for between 20 and 60 min/day for 4--7 days/week. The six studies (15%) using voluntary wheel running generally allowed longer wheel access (2--24 h/day \[[@CR87], [@CR97], [@CR98], [@CR99]••, [@CR100]••\] but see \[[@CR101]\]) for 4--7 days per week. However, it should be noted that the actual running time in voluntary exercise paradigms is unknown because rodents do not necessarily engage in constant running during periods of wheel access. The duration of the voluntary running paradigms ranged between 1 and 12 weeks, but most lasted between 2 and 4 weeks. Furthermore, only one study using voluntary exercise reported the average running velocity: Pitcher et al. \[[@CR100]••\] showed that the average velocity of both sham and OA groups was approximately 45 m/min, which is comparable to other studies using voluntary wheel running \[[@CR102]•, [@CR103]\]. On the other hand, the maximal velocity at which rodents were forced to run on treadmills ranged between 6 and 30 m/min. While it is certainly possible to train rodents to run on a treadmill at velocities of 30 m/min, maintaining this velocity for more than a few minutes appears to require substantial aerobic pre-training (8--10 weeks) at oxygen intake levels approaching maximal capacity (i.e., VO^2^~max~) \[[@CR104]\]. In fact, some groups report difficulty in forcing rats to run faster than 20 m/min \[[@CR102]•\], and approximately 25% of mice forced to run at 12 m/min on treadmills cease running by 10--15 min, and around 50% cease running by 20--25 min \[[@CR105]\]. Considering that the forced running studies discussed here generally employed little or no pre-training prior to relatively high exercise intensities, it is somewhat surprising that rodents with painful hind paw injuries were able to complete the studies. Indeed, a number of studies reported that some rodents were excluded due to stress or refusal to run \[[@CR90], [@CR91]•, [@CR92], [@CR96], [@CR106], [@CR107]\], while another reported that some mice discontinued running at the 12 m/min velocity during the therapeutic exercise phase \[[@CR95]\]. Moreover, a number of studies indicated that electric shocks or physical encouragements were required to ensure continued running \[[@CR90], [@CR91]•, [@CR92]--[@CR94], [@CR108]^•^, [@CR109]--[@CR113], [@CR114]••, [@CR115]--[@CR117]\]. Under these conditions, the vast majority of studies (36 or 90%) reported that at least some form of therapeutic exercise was effective in reducing or reversing mechanical hypersensitivity. While three of the four studies showing no beneficial effect of therapeutic exercise on mechanical hypersensitivity initiated exercise 8 or more days after injury \[[@CR92], [@CR98], [@CR118]\], other studies using similar delays in initiation of exercise were effective \[[@CR87], [@CR91]•, [@CR114]••, [@CR116], [@CR119], [@CR120]\]. Similarly, while two of the four studies showing no beneficial effect of therapeutic exercise on mechanical hypersensitivity used voluntary exercise paradigms \[[@CR98], [@CR101]\], other studies using voluntary exercise were effective \[[@CR87], [@CR97], [@CR99]••, [@CR100]••\]. Of the 36 studies showing that exercise was effective, a few indicate that some approaches were not as effective as others \[[@CR91]•, [@CR95], [@CR99]••\]. Specifically, Stagg et al. reported that 3 weeks at a slower treadmill speed of 10 m/min did not improve mechanical hypersensitivity, whereas the same duration at a higher speed of 16 m/min was effective \[[@CR91]•\]. On the other hand, Wakaizumi et al. showed that while 2 weeks of slow running (6 m/min) was effective, 1 week of faster running (12 m/min) was not effective \[[@CR95]\]. Finally, Cormier et al. indicated that while 3 weeks of pre-training followed by 3 weeks of therapeutic running resulted in beneficial effects, 1 week of pre-training followed by 3 weeks of therapeutic running was not beneficial \[[@CR99]••\]. Importantly, in all of these cases, other studies using similar exercise parameters show effectiveness. Consequently, no particular factors appear to be consistently associated with either effectiveness or ineffectiveness of therapeutic exercise.

A total of 22 studies incorporated measures of thermal hypersensitivity (Table [2](#Tab2){ref-type="table"}). Two of these studies, both using models of diabetes-induced pain, did not observe thermal hypersensitivity in diabetic rodents \[[@CR97], [@CR110]\], which is in contrast to other studies using diabetic models \[[@CR107], [@CR113], [@CR121]\]. Of the remaining 20 studies, 16 showed that exercise was effective in reducing or reversing thermal hypersensitivity (80%). Of the four studies in which no effect of exercise was observed, three were conducted in female rats \[[@CR92], [@CR111], [@CR122]\]. Nonetheless, three other studies also using female rats showed improved thermal hypersensitivity \[[@CR123]--[@CR125]\]. Similarly, while three of the four studies in which no effect of exercise was observed utilized neuropathic pain models \[[@CR98], [@CR111], [@CR122]\], a number of other studies successfully employed therapeutic exercise against neuropathic pain-induced thermal hypersensitivity \[[@CR123]--[@CR125]\]. Therefore, among the studies considered here, therapeutic exercise appears to be an effective method of reducing thermal hypersensitivity. However, no specific factors appear to be related to exercise-induced improvements in thermal hypersensitivity.

Mechanisms of Exercise-Induced Benefits in Rodent Models of Chronic Pain {#Sec8}
------------------------------------------------------------------------

As illustrated in Tables [1](#Tab1){ref-type="table"} and [2](#Tab2){ref-type="table"}, both voluntary wheel running and forced treadmill running promote favorable outcomes in a number of physiological systems impacted by persistent pain. Exercise improves measures of neurological function in the periphery and spinal cord \[[@CR90], [@CR94], [@CR97], [@CR111], [@CR115], [@CR119], [@CR121], [@CR123]\] as well as improved musculoskeletal outcomes \[[@CR99]••, [@CR114]••, [@CR120], [@CR126]\]. In addition, exercise improved neurotrophic receptor signaling in the spinal cord and periphery \[[@CR87], [@CR97], [@CR108]•, [@CR109], [@CR111], [@CR115], [@CR122]--[@CR124]\]; restoration to pre-injury levels of cytokines and other neuroimmune products in the brainstem, spinal cord, and periphery \[[@CR87], [@CR88], [@CR90], [@CR93], [@CR96], [@CR112], [@CR113], [@CR116], [@CR117], [@CR119], [@CR121], [@CR123], [@CR124], [@CR127], [@CR128]\]; and increased endogenous opioid activity in the rostroventral medulla (RVM), spinal cord, and dorsal root ganglia (DRG) \[[@CR91]•, [@CR106], [@CR110], [@CR114]••, [@CR121], [@CR129], [@CR130]\]. Importantly, while endogenous opioid-mediated mechanisms can produce analgesia at acute post-exercise time points, some studies suggest that longer-term endogenous opioid-mediated effects also occur. Specifically, Stagg et al. \[[@CR91]•\] and Allen et al. \[[@CR114]••\] demonstrated that naloxone blocks exercise-induced analgesia even when injected at time points far beyond the potential acute effects of exercise. As such, regular exercise may induce long-term tonic changes in endogenous opioid tone that promote analgesia.

Does Exercise Alter Stress in Rodent Models of Chronic Pain? {#Sec9}
------------------------------------------------------------

Of the 43 studies discussed here, only two incorporated stress measures \[[@CR89]••, [@CR100]••\], and both employed voluntary wheel running paradigms. Sabharwal et al. demonstrated that as little as 5 days and up to 8 weeks of unrestricted access to running wheels prior to injury prevented injury-induced reductions in heart rate variability (HRV), a measure of autonomic health known to be negatively impacted by stress \[[@CR131]--[@CR134]\]^,^ reviewed in \[[@CR135]\] and chronic pain \[[@CR136]\]. In the same vein, Pitcher et al. showed that following induction of a rat model of OA, 3 weeks of modest access to running wheels (2 h/day, 4 days/week) improved both HRV and plasma levels of the stress hormone corticosterone. Pitcher et al. also assessed the relationship between exercise intensity and pain and stress outcomes \[[@CR100]••\]. Similar to studies in humans, exercise intensity (i.e., total distance, average velocity) was unrelated to the degree of benefit in both pain and stress, a finding that challenges the widely held belief that more exercise yields better outcomes. Others have shown a similar lack of accord between the intensity of voluntary running and measures of stress/reward \[[@CR137]••, [@CR138]--[@CR142]\]. Overall, relatively low levels of self-regulated exercise appear to be protective against persistent pain and persistent pain-induced stress.

Conclusions {#Sec10}
-----------

The vast majority of rodent studies discussed here report beneficial effects of exercise in models of chronic pain. These benefits were accrued from both voluntary and forced exercise paradigms incorporating a diversity of exercise characteristics. To some extent, exercise-induced improvements in rodent models of chronic pain mirror the conclusions expressed in human chronic pain meta-analyses, where no intensity or approach appears to be superior to another, and exercise benefits do not seem to be related to any particular facet of either the type of injury or the exercise paradigm. In fact, there appears to be only one consistent factor among rodent studies showing exercise efficacy: regular exercise. In each study, rodents are exposed to exercise on a regular basis for a period of time. Similarly, regular exercise seems to be among the most important factors underlying exercise-induced benefits in the human literature. That said, this brief review of a relatively limited body of rodent literature was not meant to be meta-analytic (i.e., incorporating comparable data from multiple sources for statistical re-analysis). As such, it is possible that it was not sufficiently refined to detect an existing relationship between certain exercise characteristics and analgesic outcomes.

How might regular exercise exert its beneficial effects independently of other exercise-related factors? A number of rodent studies suggest that exercise-induced modulation of the immune/inflammatory response may play a role \[[@CR87], [@CR88], [@CR90], [@CR93], [@CR96], [@CR112], [@CR113], [@CR116], [@CR117], [@CR119], [@CR121], [@CR123], [@CR124], [@CR127], [@CR128]\]. Indeed, stress-related changes in immune reactivity has been proposed as a major contributing factor in the development and maintenance of chronic pain \[[@CR143]\]. Exercise, particularly regular aerobic exercise, appears well placed to reduce the impact of an altered immune/inflammatory responses in chronic diseases such as diabetes and obesity \[[@CR144]--[@CR146]\]. As such, it may be similarly effective in chronic pain states. Perhaps even more prominent than the immune response, the human literature emphasizes a role for endogenous opioids in exercise-induced analgesia reviewed in \[[@CR41], [@CR65], [@CR72], [@CR73]\]. However, the apparent intensity-dependence of acute exercise for activation of the endogenous opioid system \[[@CR75]--[@CR78]\]^,^ reviewed in \[[@CR79], [@CR80]\] seems to argue against its involvement in low-intensity exercises such as walking. In the rodent exercise literature, activity of the endogenous opioid system is also widely reported \[[@CR91]•, [@CR106], [@CR110], [@CR114]••, [@CR121], [@CR129], [@CR130]\]. However, these studies employed forced treadmill running, which can be highly stressful \[[@CR102]•, [@CR147]--[@CR154]\]. Indeed, forced running is more stressful than voluntary exercise when both paradigms are compared directly \[[@CR102]•, [@CR155], [@CR156]\]. Stressors involving unpleasant, inescapable contexts (i.e., cold-water swim, restraint) and/or electric shock are commonly used to evoke stress-induced analgesia (SIA), a stress-induced reduction in pain sensitivity related to increased endogenous opioid or cannabinoid activity \[[@CR157], [@CR158]\]. By definition, the forced running paradigm is inescapable and often incorporates electric shock plates or other negative reinforcements to promote running (Fig. [1](#Fig1){ref-type="fig"}), and forced treadmill walking has been used by at least one research group as a model of stress-induced analgesia \[[@CR159]--[@CR162]\]. Of the 43 studies considered here, almost 80% employed forced running paradigms, the vast majority of which reported exercise-induced analgesia (Tables [1](#Tab1){ref-type="table"} and [2](#Tab2){ref-type="table"}). Of these, 41% indicated that negative reinforcements, in the form of electric shock or physical stimuli such as manual prodding of the rodent, were used to promote running. Only one study stated explicitly that electrical shock was *not* used to reinforce running behavior \[[@CR128]\], while another indicated that positive reinforcement (i.e., sweetened water) was used to reinforce treadmill running \[[@CR108]•\]. The remaining forced running studies did not state whether or not negative reinforcement was used. Considering the clear potential for stress-induced analgesia in forced running paradigms, it is surprising that the only two rodent studies including stress outcomes both employed voluntary running paradigms \[[@CR89]••, [@CR100]••\]. On the other hand, at least one study has reported that relatively intense forced treadmill running does not increase tail flick latencies, a common assay for stress-induced analgesia in rodents \[[@CR163]\]. In addition, forced running paradigms can activate reward centers in the rodent brain if the animals are pre-trained appropriately \[[@CR164]\], as well as produce beneficial physiological effects in some contexts \[[@CR153], [@CR165]--[@CR167]\]. Nevertheless, given the absence of stress measures in the forced running studies, it is not possible to exclude the potential contribution of stress-induced analgesic effects in their results.

While voluntary running paradigms may avoid the influence of stress-induced analgesia, it is well known that rodents will often exhibit very high levels of running behavior when given unrestricted access to running wheels, where rats have been reported to attain peak velocities of approximately 160 m/min and mice up to 210 m/min for very brief bursts \[[@CR168], [@CR169]\]. As aforementioned, high-intensity activity triggers the endogenous opioid system \[[@CR77], [@CR78]\]^,^ reviewed in \[[@CR79]\] \[[@CR80]\], and voluntary wheel running can certainly increase endogenous opioid levels \[[@CR138], [@CR139], [@CR170]--[@CR174]\]. However, such high-intensity physical activity cannot be said to represent a clinically relevant therapeutic approach for most chronic pain patients. On the other hand, evidence in rodents suggests that regular exercise may also enhance tonic activity of the opioid system beyond acute post-exercise time points \[[@CR91]•\] \[[@CR114]••\]. As such, a better understanding of the effects of long-term exercise on tonic endogenous opioid activity is needed. Only three rodent studies assessed the effect of more modest levels of voluntary exercise \[[@CR98], [@CR100]••, [@CR101]\]. Of these, only one demonstrated that exercise was effective \[[@CR100]••\], indicating that additional research directly assessing the role of stress in the analgesic effects of running is required, incorporating experimental paradigms that more accurately represent the human chronic pain population. Taken together, the human and rodent literature suggest that regular exercise, even at modest levels, can be beneficial for chronic pain. However, the current state of the literature precludes a nuanced understanding of optimal exercise parameters and putative biological mechanisms.
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